Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

19 Apr 2017 07:00

RNS Number : 6509C
System1 Group PLC
19 April 2017
 

 

 

Press Release

19 April 2017

 

System1 Group PLC (AIM: SYS1)

formerly BrainJuicer Group PLC

("System1", or "the Company")

 

Trading Update

 

System1 (formerly BrainJuicer) today releases the following update on trading for the 12 month period ended 31st March 2017.

 

As previously announced, the Company has changed its year-end from 31 December to 31 March, and this is the first financial reporting period adopting the new year-end date. The Company announced unaudited financial results for the 12 month period ended 31 December 2016 on 9 February. It will be announcing unaudited financial results for the 12 month period ended 31 March 2017, and audited financial results for the 15 month period ended 31 March 2017, on 15 June.

 

The Company has continued to trade strongly since December 2016. For the 12 month period ended 31 March 2017, vs the 12 months to 31 March 2016, revenue grew by some 27% to approximately £33m and gross profit (our main top line performance indicator) has grown by some 29% to approximately £27m. Excluding the impact of exchange rate movements the increase in revenue was approximately 13% and gross profit was some 15%. These growth rates are similar to those for the 12 month period ended 31 December 2016, as are the product mix and geographic split .

 

The Company incurred the costs related to its name change (to System1) and the associated significant re-branding exercise, during the period since 31 December 2016. Nevertheless pre-tax profit for the 12 month period ended 31 March 2017 is expected to be around £6.2m, representing 25% growth over the pre-tax profit for the 12 month period ended 31 March 2016, and in line with expectations.

 

The Company continues to be highly cash generative. Since 31 December 2016, it has paid annual employee bonus payments relating to the 12 months ended 31 December 2016 (totalling £2.4m) and yet had a cash balance of £8.3m as at 31 March 2017 (up from £7.8m as at 31 December 2016). It has no debt.

 

The Company launched its new name and re-brand on 1st April 2017 and this marks the start of a new chapter. It has built its business by applying Behavioural Science to predicting profitable marketing. Behavioural Science is based on the conviction that people use instinct, intuition and emotion to make most decisions. This is known as "System 1" thinking. Having adopted the System 1 approach to market research and launched the System 1 advertising agency ("System1 Agency"), we are now adopting the System1 name across the business. The Company will have System1 Agency to produce profitable marketing and System1 Research to predict it and, we believe, will be well positioned to help clients move towards what we call "5-star marketing" and the growth that comes with it.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is considered to be in the public domain.

 

The Company can be found at www.system1group.com.

 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)20 7043 1000

 

John Kearon, Chief Executive Officer

 

James Geddes, Chief Financial Officer

 

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Simon Bridges / Emma Gabriel

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUWVNRBWASAAR
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.